Document is current
Any future updates will be listed below
-
Authors
Liau, Shin J. https://orcid.org/0000-0001-7308-0572
Hamada, Shota https://orcid.org/0000-0003-4939-1834
Jadczak, Agathe D. https://orcid.org/0000-0002-7501-7996
Sakata, Nobuo https://orcid.org/0000-0003-0599-3235
Lalic, Samanta https://orcid.org/0000-0002-7055-3626
Tsuchiya-Ito, Rumiko https://orcid.org/0000-0002-6817-6817
Taguchi, Reina https://orcid.org/0000-0002-9285-4382
Visvanathan, Renuka https://orcid.org/0000-0002-1303-9479
Bell, J. Simon https://orcid.org/0000-0002-6115-2767
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council
Japan Society for the Promotion of Science
Department for Innovation and Skills, Government of South Australia
Hospital Research Foundation
Resthaven Incorporated
Monash University
Australian Government Research Training Program Scholarship
Monash University
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 16 October 2023
First Online: 7 November 2023
Declarations
:
: SH belongs to an endowed chair funded by donations from Mr. Kazuteru Noguchi, JSH, Towa Pharmaceutical, Sawai Pharmaceutical, and Ain Pharmaciez, and received research funding from SOMPO Care Inc. outside of this work. RV was previously a board member and a member of the clinical governance committee of Resthaven Inc. RV has received honorarium for participation in workgroups from HealthConsult Pty Ltd in relation to an Australian Government funded project. In the past, RV has received honoraria, speakers and educational grants in various combinations from Nutricia, Abbott and Nestlé. JSB has received grant funding or consulting funds from the NHMRC, Medical Research Future Fund, Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, Society of Hospital Pharmacists of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organizations unrelated to this work. All grants and consulting funds were paid to the employing institution.
: The Australian study was approved by the University of Adelaide Human Research Ethics Committee (H-2018-247), South Australian Department for Health and Wellbeing Human Research Ethics Committee (HREC/20/SAH/15), Department of Human Services External Request Evaluation Committee (EREC/RMS0432), and Monash University Human Research Ethics Committee (23620). The Japanese study was approved by the ethical review board of the Institute for Health Economics and Policy, Japan (R2-002).
: Written informed consent was obtained from all residents or their substitute decision-maker.
: All authors approved the final manuscript for publication. All participants and/or their substitute decision-maker provided consent for publication of de-identified data.
